{
  "pmcid": "11941947",
  "sha256": "2f64a47320738e73eaaca361b1586c97ae67a849f19bebb040bf29375e328500",
  "timestamp_utc": "2025-11-09T15:26:54.928266+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 15.142981229297021,
    "reading_ease": 26.488980493191036,
    "word_count": 247
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Phase I was conducted in the Outpatient Clinic and included 122 patients, 38 women and 84 men, aged 41 to 88 years, with chronic lower limb ischemia."
      },
      "Intervention": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study (conducted in phases I–III) aimed to identify health problems and assess patients’ quality of life with chronic lower limb ischemia treated in one Polish clinical center."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The Polish version of the Vascular Life Quality Questionnaire scale (consisting of five domains (subscales)) was used to assess quality of life."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Phase I was conducted in the Outpatient Clinic and included 122 patients, 38 women and 84 men, aged 41 to 88 years, with chronic lower limb ischemia."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Moreover, statistically significant differences in the quality of life were observed between the patients before and after revascularization treatment in the overall assessment and each area of the VascuQol scale."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 7,
    "max_score": 25
  }
}